Latest Period
Q4 2025
Security Snapshot
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) Institutional Ownership
CUSIP: 92511W207
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
49
Shares (Excl. Options)
5,196,096
Price
$8.31
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Symbol
- VRCA on Nasdaq
- Shares outstanding
- 8,810,762
- Price per share
- $5.62
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 5,196,096
- Total reported value
- $43,155,907
- % of total 13F portfolios
- 0%
- Share change
- +2,491,386
- Value change
- +$20,755,741
- Number of holders
- 49
- Price from insider filings
- $5.62
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value is tracked under CUSIP 92511W207.
- 49 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 49 to 4 between Q4 2025 and Q1 2026.
- Reported value moved from $43,155,907 to $93,859.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 49 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 92511W207?
CUSIP 92511W207 identifies VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 92511W207:
Significant Owners of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Manning Paul B | 50% | $28,437,789 | 8,056,031 | Paul B Manning | 25 Nov 2025 | |||
| Caligan Partners LP | 10% | 0% | $43,635,492 | 6,503,054 | 0% | Caligan Partners LP | 26 Dec 2025 | |
| Affinity Asset Advisors, LLC | 5.5% | +0.6% | $7,346,762 | 884,172 | 0% | Affinity Asset Advisors, LLC | 22 Jan 2026 | |
| ARMISTICE CAPITAL, LLC | 5% | -25% | $3,649,153 | -$1,656,149 | 439,657 | -31% | Armistice Capital, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 49 institutional investors reported holding 5,196,096 shares of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA). This represents 59% of the company’s total 8,810,762 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 13% | 1,118,925 | +75% | 0.23% | $9,298,267 |
| Caligan Partners LP | 10% | 923,910 | 0% | 0.7% | $7,677,692 |
| Affinity Asset Advisors, LLC | 8% | 707,338 | 0.42% | $5,877,979 | |
| Velan Capital Investment Management LP | 5.4% | 471,559 | 2.3% | $3,918,655 | |
| Stonepine Capital Management, LLC | 4% | 353,669 | 2.3% | $2,938,989 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 3.2% | 280,734 | 0% | 0.06% | $2,332,900 |
| Kalehua Capital Management LLC | 2.7% | 235,779 | 0% | 2% | $1,959,323 |
| DAFNA Capital Management LLC | 2% | 173,451 | 0.33% | $1,441,378 | |
| VANGUARD GROUP INC | 1.6% | 138,194 | -39% | 0% | $1,148,392 |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 118,218 | 0% | $982,392 | |
| JANE STREET GROUP, LLC | 1.2% | 101,722 | 0% | $845,310 | |
| MARSHALL WACE, LLP | 0.97% | 85,173 | 0% | $707,786 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.77% | 67,659 | 0% | 0% | $562,388 |
| TWO SIGMA ADVISERS, LP | 0.5% | 44,430 | 0% | $369,213 | |
| Squarepoint Ops LLC | 0.38% | 33,270 | 0% | $276,474 | |
| Sovran Advisors, LLC | 0.37% | 32,658 | -56% | 0.02% | $248,527 |
| RENAISSANCE TECHNOLOGIES LLC | 0.3% | 26,400 | -9.6% | 0% | $219,384 |
| Mariner, LLC | 0.28% | 24,544 | -0.02% | 0% | $203,961 |
| STATE STREET CORP | 0.27% | 23,481 | +14% | 0% | $195,127 |
| MILLENNIUM MANAGEMENT LLC | 0.26% | 23,123 | -68% | 0% | $192,152 |
| OMERS ADMINISTRATION Corp | 0.26% | 22,600 | 0% | $187,806 | |
| MORGAN STANLEY | 0.25% | 22,009 | +1.5% | 0% | $182,894 |
| NORTHERN TRUST CORP | 0.23% | 20,024 | -0.03% | 0% | $166,400 |
| GOLDMAN SACHS GROUP INC | 0.21% | 18,621 | 0% | $154,741 | |
| HRT FINANCIAL LP | 0.2% | 17,356 | 0% | $144,000 |